Organization Profile

Crescita Therapeutics Inc.

Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that...

You just read:

Crescita Therapeutics™ Reports 2018 Third Quarter Results Strong Royalty Revenue and Achievement of First Pliaglis US Sales Milestone Positive Adjusted EBITDA of $0.8M

News provided by

Crescita Therapeutics Inc.

Nov 09, 2018, 07:30 ET